Get started
Author

Kris Mooren

Observed names: K J Mooren, K Mooren, Kris J M Mooren, Kris J. M. Mooren, Kris J.M. Mooren, Kris JM Mooren, Mooren K, Mooren, K.J.M., Mooren, Kris J. M.
ORCID: 0000-0001-7815-0488
Observed ORCID: 0000-0001-7815-0488
OpenAlex ID: A5050489389
Attitudes toward opioids for refractory dyspnea in COPD among Dutch chest physicians
2015 · Daisy JA Janssen, SM de Hosson, et al. · Chronic Respiratory Disease · 66
Digital versus analogue chest drainage system in patients with primary spontaneous pneumothorax: a randomized controlled trial
2020 · Dieuwertje Ruigrok, Peter W. A. Kunst, et al. · BMC Pulmonary Medicine · 16
PDF
The Attitudes of Pulmonologists Regarding Smoking Behavior of Their Patients with Advanced COPD: A Qualitative Research
2019 · K Mooren, GGH van der Linden, et al. · International Journal of COPD · 15
PDF
COPD patients in need of palliative care: Identification after hospitalization through the surprise question
2018 · Dionne Noppe, Hans in ‘t Veen, et al. · Chronic Respiratory Disease · 14
“When I am breathless now, I don’t have the fear that’s linked to it”: a case series on the potential of EMDR to break the dyspnea-anxiety cycle in COPD
2022 · Kris Mooren, Kirsten Smit, et al. · BMC Pulmonary Medicine · 11
PDF
Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD)
2021 · Marlies van Dijk, Kris J. M. Mooren, et al. · BMC Pulmonary Medicine · 11
PDF
Filling the Gap: A Feasibility Study of a COPD-Specific Breathlessness Service
2022 · Kris Mooren, Danielle Wester, et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 8
PDF
“This is What Lies Ahead”. Perspectives of Oxygen-Naïve COPD Patients on Long-Term Oxygen Use. A Qualitative Study
2023 · Kris Mooren, Eline M Atsma, et al. · International Journal of COPD · 6
PDF
The evolution of breathlessness management
2023 · Kris Mooren, David Currow · Annals of Palliative Medicine · 2
PDF
Fentanyl or morphine for persistent dyspnoea in COPD: a multicentre randomised crossover trial
2026 · Marlies van Dijk, Kris J.M. Mooren, et al. · European Respiratory Journal · 1
The ongoing battle against breathlessness
2024 · Kris Mooren, Huib A M Kerstjens · The Lancet Respiratory Medicine · 1
[Treatment of anxiety in COPD with CBT].
2022 · Judith A Godschalx-Dekker, Kris J M Mooren · PubMed · 1
A Proposed Consensus Definition of Severe COPD: a modified Delphi Study
2026 · Mireille C Melles, Marlies van Dijk, et al. · Annals of the American Thoracic Society
PDF
Navigating Conversations About an Uncertain Future—Buckling Up Beside Them
2026 · Olaf P. Geerse, Kris Mooren · JAMA Network Open
Post-prescribing, self-reported long-term oxygen use in people with chronic obstructive pulmonary disease and severe and very severe breathlessness
2026 · Slavica Kochovska, Sungwon Chang, et al. · Palliative Medicine in Practice
PDF
Morphine or Fentanyl for Refractory Dyspnea in COPD: a multicenter, cross-over RCT
2025 · Marlies van Dijk, Kris Mooren, et al.
Fear of suffocation in patients hospitalized with chronic respiratory disease: Results from a flashmob trial
2025 · Kris Mooren, Marcel van Dijk, et al. · Palliative Medicine
[Advance care planning in COPD].
2023 · Anne-Marije Buiter-van der Meer, Kris Mooren, et al. · PubMed
PDF
“When I am breathless now, I don’t have the fear that’s linked to it.” A qualitative case series analysis on the potential of EMDR to break the dyspnea-anxiety cycle in patients with COPD
2022 · K J Mooren, K Smit, et al. · 01.02 - Rehabilitation and chronic care
Is it possible to have a chronic obstructive pulmonary disease (COPD) specific breathlessness service in the Netherlands?
2021 · Kris Mooren · http://isrctn.com/
The Dutch Pneumothorax Study: analogue versus digital drainage in PSP, a randomized trial
2019 · Marielle Blacha, Dieuwertje Ruigrok, et al.
Works count: 26
Citation count: 152
H-index: 7
I10-index: 6
Year
Topic
Type